Details for New Drug Application (NDA): 209665
✉ Email this page to a colleague
NDA 209665 describes CISATRACURIUM BESYLATE PRESERVATIVE FREE, which is a drug marketed by Accord Hlthcare, Eugia Pharma, Fresenius Kabi Usa, Hainan Poly, Hengrui Pharma, Sandoz Inc, and Somerset Theraps Llc, and is included in seven NDAs. It is available from seven suppliers. Additional details are available on the CISATRACURIUM BESYLATE PRESERVATIVE FREE profile page.
The generic ingredient in CISATRACURIUM BESYLATE PRESERVATIVE FREE is cisatracurium besylate. There are nine drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the cisatracurium besylate profile page.
The generic ingredient in CISATRACURIUM BESYLATE PRESERVATIVE FREE is cisatracurium besylate. There are nine drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the cisatracurium besylate profile page.
Summary for 209665
| Tradename: | CISATRACURIUM BESYLATE PRESERVATIVE FREE |
| Applicant: | Eugia Pharma |
| Ingredient: | cisatracurium besylate |
| Patents: | 0 |
Pharmacology for NDA: 209665
| Physiological Effect | Neuromuscular Nondepolarizing Blockade |
Suppliers and Packaging for NDA: 209665
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| CISATRACURIUM BESYLATE PRESERVATIVE FREE | cisatracurium besylate | INJECTABLE;INJECTION | 209665 | ANDA | Eugia US LLC | 55150-284 | 55150-284-10 | 10 VIAL, SINGLE-DOSE in 1 CARTON (55150-284-10) / 5 mL in 1 VIAL, SINGLE-DOSE (55150-284-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 2MG BASE/ML | ||||
| Approval Date: | Oct 27, 2020 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
